• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在未接受手术治疗的感染性心内膜炎患者中使用手术风险评分。

Using surgical risk scores in nonsurgically treated infective endocarditis patients.

机构信息

Division of Cardiac Surgery, Trieste University Hospital, Trieste, Italy.

Department of Thoracic and Cardiovascular Surgery, Jean Minjoz University Hospital, Besançon, France.

出版信息

Hellenic J Cardiol. 2020 Jul-Aug;61(4):246-252. doi: 10.1016/j.hjc.2019.01.008. Epub 2019 Jan 26.

DOI:10.1016/j.hjc.2019.01.008
PMID:30690140
Abstract

BACKGROUND

The accuracy of surgical scores in predicting in-hospital mortality for nonsurgically treated patients with infective endocarditis (IE) has not yet been explored.

METHODS

Patients with definite IE who did not undergo valve surgery were selected from the database of seven French administrative areas (Association pour l'Étude et la Prévention de l'Endocardite Infectieuse [AEPEI] Registry, 2008). The patients were scored using (a) six systems specifically devised to predict in-hospital mortality after surgery for IE, (b) three commonly used risk scores for heart surgery, and (c) a risk score for predicting six-month mortality in IE after either surgery or medical therapy. Calibration (Hosmer-Lemeshow test) and discriminatory power (receiver operating characteristic [ROC] analysis) were assessed for each score. Areas under ROC curves were compared one-to-one (Hanley-McNeil method).

RESULTS

A total of 192 patients (mean age, 65.2±15.2 years) were considered for analysis. There were 38 (19.8%) in-hospital deaths. Age >70 years (p=0.001), Staphylococcus aureus as causal agent (p=0.05), and severe sepsis (p=0.027) were independent predictors of in-hospital mortality. Despite many differences in the number and type of variables, all but two of the investigated scores showed good calibration (p>0.66). However, discriminatory power was satisfactory (area under ROC curve >0.70) only for three of the scores specific for IE and two of the scores used to predict mortality after cardiac surgery.

CONCLUSIONS

Among the 10 surgical scores evaluated in this study, five could be adopted to predict in-hospital mortality even for IE patients receiving medical treatment only.

摘要

背景

手术评分预测非手术治疗感染性心内膜炎(IE)患者院内死亡率的准确性尚未得到探索。

方法

从七个法国行政区的数据库中选择未接受瓣膜手术的明确 IE 患者(感染性心内膜炎预防和研究协会[AEPEI]注册处,2008 年)。使用(a)专门设计用于预测 IE 手术后院内死亡率的六个系统,(b)三种常用于心脏手术的风险评分,以及(c)一种用于预测手术或药物治疗后 IE 六个月死亡率的风险评分,对患者进行评分。对每个评分进行校准(Hosmer-Lemeshow 检验)和判别能力(接受者操作特征[ROC]分析)评估。ROC 曲线下面积逐个比较(Hanley-McNeil 方法)。

结果

共纳入 192 例患者(平均年龄 65.2±15.2 岁)进行分析。有 38 例(19.8%)院内死亡。年龄>70 岁(p=0.001)、金黄色葡萄球菌作为病原体(p=0.05)和严重脓毒症(p=0.027)是院内死亡率的独立预测因素。尽管调查评分的变量数量和类型存在许多差异,但除了两个评分外,所有评分的校准均较好(p>0.66)。然而,只有三个针对 IE 的评分和两个用于预测心脏手术后死亡率的评分具有令人满意的判别能力(ROC 曲线下面积>0.70)。

结论

在本研究中评估的 10 个手术评分中,有 5 个可用于预测仅接受药物治疗的 IE 患者的院内死亡率。

相似文献

1
Using surgical risk scores in nonsurgically treated infective endocarditis patients.在未接受手术治疗的感染性心内膜炎患者中使用手术风险评分。
Hellenic J Cardiol. 2020 Jul-Aug;61(4):246-252. doi: 10.1016/j.hjc.2019.01.008. Epub 2019 Jan 26.
2
Risk scores and surgery for infective endocarditis: in search of a good predictive score.风险评分与感染性心内膜炎手术:寻找良好的预测评分。
Scand Cardiovasc J. 2019 Jun;53(3):117-124. doi: 10.1080/14017431.2019.1610188. Epub 2019 May 13.
3
Predictive performance of surgical mortality risk scores in infective endocarditis.感染性心内膜炎手术死亡风险评分的预测性能
Eur J Cardiothorac Surg. 2024 Jan 2;65(1). doi: 10.1093/ejcts/ezad433.
4
Prediction of 30-day mortality after surgery for infective endocarditis using risk scores: Insights from a European multicenter comparative validation study.利用风险评分预测感染性心内膜炎手术后 30 天死亡率:来自欧洲多中心比较验证研究的见解。
Am Heart J. 2024 Sep;275:108-118. doi: 10.1016/j.ahj.2024.05.021. Epub 2024 Jun 6.
5
Simple Scoring System to Predict In-Hospital Mortality After Surgery for Infective Endocarditis.预测感染性心内膜炎手术后院内死亡率的简易评分系统。
J Am Heart Assoc. 2017 Jul 20;6(7):e004806. doi: 10.1161/JAHA.116.004806.
6
Does EuroSCORE predict length of stay and specific postoperative complications after cardiac surgery?欧洲心脏手术风险评估系统(EuroSCORE)能否预测心脏手术后的住院时间及特定术后并发症?
Eur J Cardiothorac Surg. 2005 Jan;27(1):128-33. doi: 10.1016/j.ejcts.2004.09.020.
7
Analysis of Risk Scores to Predict Mortality in Patients Undergoing Cardiac Surgery for Endocarditis.预测心内膜炎心脏手术患者死亡率的风险评分分析
Arq Bras Cardiol. 2020 May-Jun;114(3):518-524. doi: 10.36660/abc.20190050.
8
Assessment of perioperative mortality risk in patients with infective endocarditis undergoing cardiac surgery: performance of the EuroSCORE I and II logistic models.接受心脏手术的感染性心内膜炎患者围手术期死亡风险评估:欧洲心脏手术风险评估系统I和II逻辑模型的表现
Interact Cardiovasc Thorac Surg. 2016 Feb;22(2):141-8. doi: 10.1093/icvts/ivv304. Epub 2015 Nov 6.
9
Prognostic assessment of valvular surgery in active infective endocarditis: multicentric nationwide validation of a new score developed from a meta-analysis.活动性感染性心内膜炎瓣膜手术的预后评估:一项基于荟萃分析得出的新评分的多中心全国性验证
Eur J Cardiothorac Surg. 2020 Apr 1;57(4):724-731. doi: 10.1093/ejcts/ezz328.
10
Risk score for cardiac surgery in active left-sided infective endocarditis.活动性左侧感染性心内膜炎心脏手术的风险评分
Heart. 2017 Sep;103(18):1435-1442. doi: 10.1136/heartjnl-2016-311093. Epub 2017 Apr 21.

引用本文的文献

1
Prediction of hospital mortality in patients with left-sided infective endocarditis using a score in the first hours of admission.入院最初数小时使用评分预测左侧感染性心内膜炎患者的医院死亡率。
Sci Rep. 2025 Aug 5;15(1):28566. doi: 10.1038/s41598-025-13592-1.
2
Mitral valve repair and replacement in infectious endocarditis: a systematic review and meta-analysis of clinical outcome.感染性心内膜炎中二尖瓣修复与置换术:临床结局的系统评价与荟萃分析
Egypt Heart J. 2024 Oct 4;76(1):134. doi: 10.1186/s43044-024-00564-5.
3
Perioperative risk stratification scores in infective endocarditis and its usefulness.
感染性心内膜炎围手术期风险分层评分及其效用
Indian J Thorac Cardiovasc Surg. 2024 May;40(Suppl 1):47-60. doi: 10.1007/s12055-023-01644-y. Epub 2023 Dec 18.
4
Vancomycin-Resistant : A Case Report of Bacterial Endocarditis and Review of Literature on Infections Caused by This Pathogen.耐万古霉素:一例细菌性心内膜炎病例报告及该病原体所致感染的文献综述
Microorganisms. 2024 Mar 12;12(3):566. doi: 10.3390/microorganisms12030566.
5
Performance of the SHARPEN Score and the Charlson Comorbidity Index for In-Hospital and Post-Discharge Mortality Prediction in Infective Endocarditis.SHARPEN 评分和 Charlson 合并症指数在感染性心内膜炎住院和出院后死亡率预测中的表现。
Arq Bras Cardiol. 2024 Mar 4;120(12):e20230441. doi: 10.36660/abc.20230441. eCollection 2024.
6
Contemporary risk models for infective endocarditis surgery: a narrative review.当代感染性心内膜炎手术风险模型:叙事性综述。
Ther Adv Cardiovasc Dis. 2023 Jan-Dec;17:17539447231193291. doi: 10.1177/17539447231193291.
7
Infective endocarditis: Do we have an effective risk score model? A systematic review.感染性心内膜炎:我们有有效的风险评分模型吗?一项系统综述。
Front Cardiovasc Med. 2023 Feb 20;10:1093363. doi: 10.3389/fcvm.2023.1093363. eCollection 2023.
8
Risk scores' performance and their impact on operative decision-making in left-sided endocarditis: a cohort study.风险评分在左侧心内膜炎手术决策中的表现及其影响:一项队列研究。
Eur J Clin Microbiol Infect Dis. 2023 Jan;42(1):33-42. doi: 10.1007/s10096-022-04516-2. Epub 2022 Nov 8.
9
Infective endocarditis and outcomes of valve surgery: the bug, the valve, the host and the unknown.感染性心内膜炎与瓣膜手术的结局:病原体、瓣膜、宿主及未知因素
J Thorac Dis. 2019 Oct;11(10):E178-E181. doi: 10.21037/jtd.2019.09.51.
10
Prognostic factors of mortality after surgery in infective endocarditis: systematic review and meta-analysis.感染性心内膜炎手术后死亡率的预后因素:系统评价和荟萃分析。
Infection. 2019 Dec;47(6):879-895. doi: 10.1007/s15010-019-01338-x. Epub 2019 Jun 28.